0
Bio-Techne Banner Image

Bio-Techne

  • Ticker TECH
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Bio-Techne Logo Image
  • 1001-5000 Employees
  • Based in Minneapolis, Minnesota
Techne Corporation develops, manufactures, and sells biotechnology products and clinical diagnostic controls worldwide. It operates in two segments, Biotechnology and Clinical Controls. The Biotechnology segment provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits used by researchersMore to quantify the level of a specific protein in biological fluids, such as serum, plasma, or urine; and clinical diagnostic immunoassay kits consisting of erythropoietin, transferrin receptor, and Beta2-microglobulin immunoassays for use as in vitro diagnostic devices.
Bio-Techne

Most Recent Responsibility Report

Bio-Techne
MOST RECENT 2022 Corporate Sustainability Report

Archived Responsibility Reports

Our service enables potential investors to review the most recent and archived Bio-Techne Sustainability Report, Bio-Techne Corporate Social Responsibility Report, Bio-Techne CSR Report, Bio-Techne Corporate Responsibility, Bio-Techne CR Report, Bio-Techne Citizenship Report, Bio-Techne ESG Report, and Bio-Techne Environmental Report online.